News on noninvasive prenatal testing, carrier screening, and preimplantation genetic screening.
The firms have agreed to develop infectious disease and women's heath testing assays using SpeeDx's proprietary technology.
The new firm will offer target enrichment assays for clinical NGS testing and develop library preparation kits for clinical tests on Illumina's sequencing platform.
Earlier this month, the company started accepting clinical samples at its CLIA/CAP laboratory in Pittsburgh and an affiliate laboratory in Malaysia.
Researchers at Baylor College of Medicine and Columbia University found that almost all blood samples from pregnant women tested contained several trophoblasts.
The genomics-focused fertility management company claims that 23andMe failed to meet its contractual obligations within a research collaboration.
